查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
亞太地區 PCR 技術市場預測至 2030 年 - 區域分析 - 按技術、產品、應用和最終用戶
市場調查報告書
商品編碼
1562194

亞太地區 PCR 技術市場預測至 2030 年 - 區域分析 - 按技術、產品、應用和最終用戶

Asia Pacific PCR Technologies Market Forecast to 2030 - Regional Analysis - by Technology, Offerings, Application, and End User
出版日期: | 出版商: The Insight Partners | 英文 148 Pages | 訂單完成後即時交付

價格

亞太地區PCR技術市場預計將從2022年的28.352億美元成長到2030年的54.656億美元。

PCR 技術投資和資金供應激增，推動亞太 PCR 技術市場發展

到2023 年，全球政府和聯邦機構將認知到定量聚合酶鍊式反應(qPCR) 和dPCR 產品在基於基因組的研究中的作用，Mirxes 是RNA 技術的領先創新者，專門從事準確、非侵入性且價格合理的血液檢測用於早期疾病檢測（特別是癌症）的 miRNA 檢測試劑盒在 D 輪融資中籌集了 5000 萬美元。該公司的主要產品 GASTROClear 是一種體外診斷測試，使用 PCR 來早期檢測胃癌。它已被美國 FDA 指定為突破性設備。這是美國FDA首次對用於胃癌早期診斷的IVD檢測、東南亞的分子IVD檢測以及全球範圍內的血液miRNA檢測給予這樣的分類。有些公司也加大了研發經費，用於基因合成的增強。 2022年，淡馬錫向位於印度的健康科技企業Molbio Diagnostics投資了8,500萬美元。 Molbio 設計了針對多種疾病的攜帶式診斷工具，包括愛滋病毒、登革熱、瘧疾、肝炎和結核病 (TB)。 2021 年，在 E+ 輪融資中，中國一家生產分子診斷工具的床邊護理 (POC) 企業 Ustar 籌集了約 260 萬美元。 Ustar將使用籌集的部分資金來提高其旗艦高通量、全自動核酸擴增測試儀器的有效性。剩餘資金將用於開發下一代檢測平台、增加所提供的檢測種類以及大量生產家用聚合酶鏈反應（PCR）檢測套件。

因此，疾病特異性基因組學研究和開發的財政支持不斷增加，推動了對 PCR 技術的需求。

亞太地區 PCR 技術市場概況

亞太地區 PCR 技術市場分為中國、日本、印度、韓國、澳洲和亞太地區其他地區。亞太地區的市場成長主要歸因於外國直接投資的增加；擁有大量高技能、高效率的勞動力；簡化政府政策，進而增加對生技領域的投資。此外，傳染病和慢性病病例的增加以及政府和非政府措施推動了亞太地區 PCR 技術市場的成長。預測期內中國PCR技術市場的預期成長歸因於對高品質醫療保健產品的需求不斷增加、中國生活方式疾病的盛行率不斷上升、診斷技術的不斷發展、診斷中心和醫院數量的激增、以及醫院醫療設施的持續現代化。在中國，PCR技術用於植入前遺傳學診斷（PGD）、癌症治療和非侵入性產前檢測（NIPT）。根據2023年2月發表的《罕見疾病日：為何中國的罕見疾病負擔可能成為創新機會》一文，中國約有2,000萬人患有罕見疾病。 dPCR 和 qPCR 等 PCR 技術可用於此類罕見疾病的診斷和治療（以監測治療反應）。中國癌症盛行率的上升也促進了 PCR 技術市場的成長。根據全球癌症觀察站的資料，2020年中國報告約460萬癌症病例。中國PCR技術市場收入及2030年預測（百萬美元） 從價值來看，2022年中國PCR技術市場價值為7,7623萬美元，預計2030年將達到15,4521萬美元；預計在預測期內複合年成長率為 9.00%。

亞太地區 PCR 技術市場營收及 2030 年預測（百萬美元）

亞太地區 PCR 技術市場區隔

亞太地區 PCR 技術市場分為技術、產品、應用、最終用戶和國家。

根據技術，亞太地區PCR技術市場分為即時PCR、常規PCR、逆轉錄、數位PCR、多重RTPCR、熱啟動PCR等。 2022 年，即時 PCR 領域在亞太 PCR 技術市場中佔據最大佔有率。

在產品方面，亞太地區 PCR 技術市場分為試劑和耗材、儀器以及軟體和服務。到2022年，試劑和耗材細分市場在亞太地區PCR技術市場中佔據最大佔有率。此外，西林瓶尺寸分為0.2ml至2ml、0.1ml至0.3ml、2ml至5ml等西林瓶。此外，儀器部分分為桌上型 PCR 和攜帶式熱循環儀/PCR。

依應用分類，亞太地區 PCR 技術市場細分為基因表現分析、基因定序、基因分型、核酸合成、標準驗證、護理診斷應用、環境應用等。 2022 年，基因表現分析領域佔據亞太 PCR 技術市場的最大佔有率。

根據最終用戶，亞太地區 PCR 技術市場分為醫院和診斷中心、製藥和生物技術公司、學術機構和研究實驗室等。 2022 年，醫院和診斷中心細分市場佔據亞太 PCR 技術市場的最大佔有率。

依國家分類，亞太地區 PCR 技術市場分為中國、日本、印度、澳洲、韓國和亞太地區其他地區。 2022 年，中國將主導亞太 PCR 技術市場。

Thermo Fisher Scientific Inc、Promega Corp、QIAGEN NV、bioMerieux SA、Hoffmann-La Roche Ltd、Bio-Rad Laboratories Inc、Becton Dickinson and Co、Takara Bio Inc、Standard Bio Tools Inc、Agilent Technologies Inc 和 Ellume Ltd 等亞太PCR 技術市場的領先公司。

目錄

第 1 章：簡介

第 2 章：執行摘要

  • 主要見解

第 3 章：研究方法

  • 覆蓋範圍
  • 二次研究
  • 初步研究

第 4 章：亞太 PCR 技術市場 - 主要產業動態

  • PCR 技術市場 - 主要產業動態
  • 市場促進因素
    • 遺傳性疾病和傳染病的盛行率不斷上升
    • PCR 技術的投資和資金供應激增
  • 市場限制
    • PCR 系統的高成本和替代檢測的可用性
  • 市場機會
    • 新興國家擴大採用 PCR 技術
    • POC 測試需求不斷增加
  • 未來趨勢
    • PCR 技術的進步
  • 促進因素和限制的影響：

第 5 章：PCR 技術市場 - 亞太市場分析

  • PCR 技術市場收入，2020 - 2030

第 6 章：亞太地區 PCR 技術市場分析 - 依技術

  • 概述
  • 即時螢光定量PCR
  • 常規PCR
  • 逆轉錄聚合酶連鎖反應
  • 數位PCR
  • 多重逆轉錄聚合酶連鎖反應
  • 熱啟動PCR
  • 其他

第 7 章：亞太地區 PCR 技術市場分析 - 按產品

  • 概述
  • 2022 年和 2030 年 PCR 技術市場收入佔有率（按產品分類）（%）
  • 試劑及耗材
  • 儀器儀表
  • 軟體和服務

第 8 章：亞太地區 PCR 技術市場分析 - 按應用

  • 概述
  • 2022 年和 2030 年 PCR 技術市場收入佔有率，按應用分類 (%)
  • 基因表現分析
  • 基因定序
  • 基因分型
  • 核酸合成
  • 標準驗證
  • 照護端診斷
  • 環境應用
  • 其他

第 9 章：亞太地區 PCR 技術市場分析 - 按最終用戶

  • 概述
  • 2022 年和 2030 年 PCR 技術市場收入佔有率（按最終用戶分類）（%）
  • 醫院和診斷中心
  • 學術界及研究機構
  • 製藥和生物技術公司
  • 其他

第 10 章：亞太地區 PCR 技術市場 - 國家分析

  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 亞太地區其他地區

第 11 章：PCR 技術市場-產業格局

  • 概述
  • PCR 技術市場的成長策略
  • 無機成長策略
    • 概述
  • 有機成長策略
    • 概述

第 12 章：公司簡介

  • Thermo Fisher Scientific Inc
  • Promega Corp
  • QIAGEN NV
  • bioMerieux SA
  • Hoffmann-La Roche Ltd
  • Bio-Rad Laboratories Inc
  • Becton Dickinson and Co
  • Takara Bio Inc
  • Standard Biotools Inc
  • Agilent Technologies Inc
  • Ellume Ltd

第 13 章：附錄

Product Code: BMIRE00030379

The Asia Pacific PCR technologies market is expected to grow from US$ 2,835.20 million in 2022 to US$ 5,465.60 million by 2030. It is estimated to record a CAGR of 8.6% from 2022 to 2030.

Surging Investments and Funds Availability for PCR Technologies Boost Asia Pacific PCR Technologies Market

Government and federal agencies worldwide recognize the role of quantitative polymerase chain reaction (qPCR) and dPCR products in genome-based research in 2023, Mirxes, a leading innovator in RNA technology, specializes in accurate, non-invasive, and reasonably priced blood-based miRNA testing kits for early disease detection, particularly cancer, raised US $50 million in a Series D funding round. The company's main offering, GASTROClear, is an in vitro diagnostic test that uses PCR to detect stomach cancer early on. It has been designated as a Breakthrough Device by the US FDA. This is the first time that the US FDA has given such a classification to an IVD test for early diagnosis of stomach cancer, a molecular IVD test from Southeast Asia, and a blood miRNA test worldwide. Some companies have also increased their research and development funds for the enhancement of gene synthesis. In In 2022, Temasek contributed US $85 million to the healthtech business Molbio Diagnostics, located in India. Molbio designs portable diagnostic tools for a range of conditions, including HIV, dengue, malaria, hepatitis, and tuberculosis (TB). In 2021, in a Series E+ fundraising round, Ustar, a Chinese point-of-care (POC) business that creates molecular diagnostic tools, raised roughly US$ 2.6 million. Ustar will use a portion of the funds raised to improve the effectiveness of their flagship high-throughput, completely automated nucleic acid amplification test instrument. The remaining funds will go into developing a next generation testing platform, increasing the variety of tests offered, and mass-producing polymerase chain reaction (PCR) testing kits for home usage.

Therefore, the increasing availability of financial support for research and development in disease-specific genomics propels the demand for PCR technologies.

Asia Pacific PCR Technologies Market Overview

The Asia Pacific PCR technologies market is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. The market growth in Asia Pacific is mainly attributed to the increasing foreign direct investments; the large availability of highly skilled, efficient workforces; and streamlining government policies resulting in high investments in the biotechnology sector. In addition, increasing cases of infectious and chronic diseases, and government and non-government initiatives fuel the growth of the PCR technologies market in Asia Pacific. The projected growth of the PCR technologies market in China during the forecast period is attributed to the increasing demand for high-quality healthcare products, growing prevalence of lifestyle diseases in the country, rising developments in diagnostics technologies, surging number of diagnostic centers and hospitals, and the ongoing modernization of medical facilities in hospitals. In China, PCR techniques are used for preimplantation genetic diagnosis (PGD), cancer treatment, and noninvasive prenatal testing (NIPT). According to the article "Rare Disease Day: why China's Rare Disease Burden Could Be an Opportunity for Innovation," published in February 2023, ~20 million Chinese people suffer from rare diseases. PCR techniques such as dPCR and qPCR can be used in the diagnosis and treatment (to monitor treatment response) of such rare conditions. The rising prevalence of cancer in China also contributes to the PCR technologies market growth. According to the Global Cancer Observatory data, ~4.6 million cancer cases were reported in the country in 2020. In addition, cancer resulted in the death of 3.1 million people in China. China PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn) In terms of value, the PCR technologies market in China was valued at US$ 776.23 million in 2022 and is projected to reach US$ 1,545.21 million by 2030; it is expected to register a CAGR of 9.00% during the forecast period.

Asia Pacific PCR Technologies Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific PCR Technologies Market Segmentation

The Asia Pacific PCR technologies market is segmented into technology, offerings, application, end user, and country.

Based on technology, the Asia Pacific PCR technologies market is segmented into real time PCR, conventional PCR, reverse transcription, digital PCR, multiplex RTPCR, hot start PCR, and others. The real time PCR segment held largest share of Asia Pacific PCR technologies market in 2022.

In terms of offerings, the Asia Pacific PCR technologies market is segmented into reagents & consumables, instruments, and software & services. The reagents & consumables segment held the largest share of Asia Pacific PCR technologies market in 2022. Further, reagents & consumables segment are categorized into reagents, vials size, and other consumables. Furthermore, vials size is segmented into 0.2ml to 2ml, 0.1 ml to 0.3 ml, 2 ml to 5ml, and other vials. Additionally, instruments segment is bifurcated into benchtop PCR, and portable thermocyclers/PCR.

By application, the Asia Pacific PCR technologies market is segmented gene expression analysis, genetic sequencing, genotyping, nucleic acid synthesis, standard validation, point of care diagnostic application, environmental application, and others. The gene expression analysis segment held the largest share of Asia Pacific PCR technologies market in 2022.

Based on end user, the Asia Pacific PCR technologies market is segmented hospitals & diagnostic centers, pharmaceutical & biotechnology companies, academic institutes & research laboratories, and others. The hospitals & diagnostic centers segment held the largest share of Asia Pacific PCR technologies market in 2022.

By country, the Asia Pacific PCR technologies market has been categorized into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific PCR technologies market in 2022.

Thermo Fisher Scientific Inc, Promega Corp, QIAGEN NV, bioMerieux SA, Hoffmann-La Roche Ltd, Bio-Rad Laboratories Inc, Becton Dickinson and Co, Takara Bio Inc, Standard Bio Tools Inc, Agilent Technologies Inc, and Ellume Ltd are some of the leading companies operating in the Asia Pacific PCR technologies market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Asia Pacific PCR Technologies Market - Key Industry Dynamics

  • 4.1 PCR Technologies Market - Key Industry Dynamics
  • 4.2 Market Drivers
    • 4.2.1 Rising Prevalence of Genetic and Infectious Diseases
    • 4.2.2 Surging Investments and Funds Availability for PCR Technologies
  • 4.3 Market Restraints
    • 4.3.1 High Costs of PCR Systems and Availability of Alternative Assays
  • 4.4 Market Opportunities
    • 4.4.1 Increasing Adoption of PCR Techniques in Emerging Countries
    • 4.4.2 Increasing Demand for POC Testing
  • 4.5 Future Trends
    • 4.5.1 Advancements in PCR Technologies
  • 4.6 Impact of Drivers and Restraints:

5. PCR Technologies Market - Asia Pacific Market Analysis

  • 5.1 PCR Technologies Market Revenue (US$ Million), 2020 - 2030

6. Asia Pacific PCR Technologies Market Analysis - By Technology

  • 6.1 Overview
  • 6.2 Real Time PCR
    • 6.2.1 Overview
    • 6.2.2 Real Time PCR Market, Revenue and Forecast to 2030 (US$ Million)
  • 6.3 Conventional PCR
    • 6.3.1 Overview
    • 6.3.2 Conventional PCR Market, Revenue and Forecast to 2030 (US$ Million)
  • 6.4 Reverse Transcription PCR
    • 6.4.1 Overview
    • 6.4.2 Reverse Transcription PCR Market, Revenue and Forecast to 2030 (US$ Million)
  • 6.5 Digital PCR
    • 6.5.1 Overview
    • 6.5.2 Digital PCR Market, Revenue and Forecast to 2030 (US$ Million)
  • 6.6 Multiplex RT PCR
    • 6.6.1 Overview
    • 6.6.2 Multiplex RT PCR Market, Revenue and Forecast to 2030 (US$ Million)
  • 6.7 Hot Start PCR
    • 6.7.1 Overview
    • 6.7.2 Hot Start PCR Market, Revenue and Forecast to 2030 (US$ Million)
  • 6.8 Others
    • 6.8.1 Overview
    • 6.8.2 Others Market, Revenue and Forecast to 2030 (US$ Million)

7. Asia Pacific PCR Technologies Market Analysis - By Offerings

  • 7.1 Overview
  • 7.2 PCR Technologies Market Revenue Share, by Offerings 2022 & 2030 (%)
  • 7.3 Reagents and Consumables
    • 7.3.1 Overview
    • 7.3.2 Reagents and Consumables Market, Revenue and Forecast to 2030 (US$ Million)
      • 7.3.2.1 PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Reagents and Consumables
        • 7.3.2.1.1 PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Vial Size
  • 7.4 Instruments
    • 7.4.1 Overview
    • 7.4.2 Instruments Market, Revenue and Forecast to 2030 (US$ Million)
      • 7.4.2.1 PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Instruments
  • 7.5 Software and Services
    • 7.5.1 Overview
    • 7.5.2 Software and Services Market, Revenue and Forecast to 2030 (US$ Million)

8. Asia Pacific PCR Technologies Market Analysis - By Application

  • 8.1 Overview
  • 8.2 PCR Technologies Market Revenue Share, by Application 2022 & 2030 (%)
  • 8.3 Gene Expression Analysis
    • 8.3.1 Overview
    • 8.3.2 Gene Expression Analysis Market, Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Genetic Sequencing
    • 8.4.1 Overview
    • 8.4.2 Genetic Sequencing Market, Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Genotyping
    • 8.5.1 Overview
    • 8.5.2 Genotyping Market, Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Nucleic Acid Synthesis
    • 8.6.1 Overview
    • 8.6.2 Nucleic Acid Synthesis Market, Revenue and Forecast to 2030 (US$ Million)
  • 8.7 Standard Validation
    • 8.7.1 Overview
    • 8.7.2 Standard Validation Market, Revenue and Forecast to 2030 (US$ Million)
  • 8.8 Point of Care Diagnostics
    • 8.8.1 Overview
    • 8.8.2 Point of Care Diagnostics Market, Revenue and Forecast to 2030 (US$ Million)
  • 8.9 Environmental Application
    • 8.9.1 Overview
    • 8.9.2 Environmental Application Market, Revenue and Forecast to 2030 (US$ Million)
  • 8.10 Others
    • 8.10.1 Overview
    • 8.10.2 Others Market, Revenue and Forecast to 2030 (US$ Million)

9. Asia Pacific PCR Technologies Market Analysis - By End User

  • 9.1 Overview
  • 9.2 PCR Technologies Market Revenue Share, by End User 2022 & 2030 (%)
  • 9.3 Hospitals and Diagnostic Centers
    • 9.3.1 Overview
    • 9.3.2 Hospitals and Diagnostic Centers Market, Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Academia and Research Institutes
    • 9.4.1 Overview
    • 9.4.2 Academia and Research Institutes Market, Revenue and Forecast to 2030 (US$ Million)
  • 9.5 Pharmaceutical and Biotechnology Companies
    • 9.5.1 Overview
    • 9.5.2 Pharmaceutical and Biotechnology Companies Market, Revenue and Forecast to 2030 (US$ Million)
  • 9.6 Others
    • 9.6.1 Overview
    • 9.6.2 Others Market, Revenue and Forecast to 2030 (US$ Million)

10. Asia Pacific PCR Technologies Market -Country Analysis

  • 10.1 Asia Pacific: PCR Technologies Market
    • 10.1.1 Overview
    • 10.1.2 Asia Pacific PCR Technologies Market Revenue and Forecast and Analysis - By Country
      • 10.1.2.1 China
        • 10.1.2.1.1 Overview
      • 10.1.2.2 China PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.2.1 China PCR Technologies Market Breakdown by Technology
        • 10.1.2.2.2 China PCR Technologies Market Breakdown by Offerings
        • 10.1.2.2.2.1 China PCR Technologies Market Breakdown by Instruments
        • 10.1.2.2.2.2 China PCR Technologies Market Breakdown by Reagents and Consumables
        • 10.1.2.2.2.2.1 China PCR Technologies Market Breakdown by Vial Size
        • 10.1.2.2.3 China PCR Technologies Market Breakdown by Application
        • 10.1.2.2.4 China PCR Technologies Market Breakdown by End User
      • 10.1.2.3 Japan
        • 10.1.2.3.1 Overview
      • 10.1.2.4 Japan PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.4.1 Japan PCR Technologies Market Breakdown by Technology
        • 10.1.2.4.2 Japan PCR Technologies Market Breakdown by Offerings
        • 10.1.2.4.2.1 Japan PCR Technologies Market Breakdown by Instruments
        • 10.1.2.4.2.2 Japan PCR Technologies Market Breakdown by Reagents and Consumables
        • 10.1.2.4.2.2.1 Japan PCR Technologies Market Breakdown by Vial Size
        • 10.1.2.4.3 Japan PCR Technologies Market Breakdown by Application
        • 10.1.2.4.4 Japan PCR Technologies Market Breakdown by End User
      • 10.1.2.5 India
        • 10.1.2.5.1 Overview
      • 10.1.2.6 India PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.6.1 India PCR Technologies Market Breakdown by Technology
        • 10.1.2.6.2 India PCR Technologies Market Breakdown by Offerings
        • 10.1.2.6.2.1 India PCR Technologies Market Breakdown by Instruments
        • 10.1.2.6.2.2 India PCR Technologies Market Breakdown by Reagents and Consumables
        • 10.1.2.6.2.2.1 India PCR Technologies Market Breakdown by Vial Size
        • 10.1.2.6.3 India PCR Technologies Market Breakdown by Application
        • 10.1.2.6.4 India PCR Technologies Market Breakdown by End User
      • 10.1.2.7 Australia
        • 10.1.2.7.1 Overview
      • 10.1.2.8 Australia PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.8.1 Australia PCR Technologies Market Breakdown by Technology
        • 10.1.2.8.2 Australia PCR Technologies Market Breakdown by Offerings
        • 10.1.2.8.2.1 Australia PCR Technologies Market Breakdown by Instruments
        • 10.1.2.8.2.2 Australia PCR Technologies Market Breakdown by Reagents and Consumables
        • 10.1.2.8.2.2.1 Australia PCR Technologies Market Breakdown by Vial Size
        • 10.1.2.8.3 Australia PCR Technologies Market Breakdown by Application
        • 10.1.2.8.4 Australia PCR Technologies Market Breakdown by End User
      • 10.1.2.9 South Korea
        • 10.1.2.9.1 Overview
      • 10.1.2.10 South Korea PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.10.1 South Korea PCR Technologies Market Breakdown by Technology
        • 10.1.2.10.2 South Korea PCR Technologies Market Breakdown by Offerings
        • 10.1.2.10.2.1 South Korea PCR Technologies Market Breakdown by Instruments
        • 10.1.2.10.2.2 South Korea PCR Technologies Market Breakdown by Reagents and Consumables
        • 10.1.2.10.2.2.1 South Korea PCR Technologies Market Breakdown by Vial Size
        • 10.1.2.10.3 South Korea PCR Technologies Market Breakdown by Application
        • 10.1.2.10.4 South Korea PCR Technologies Market Breakdown by End User
      • 10.1.2.11 Rest of Asia Pacific
        • 10.1.2.11.1 Overview
      • 10.1.2.12 Rest of Asia Pacific PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.12.1 Rest of Asia Pacific PCR Technologies Market Breakdown by Technology
        • 10.1.2.12.2 Rest of Asia Pacific PCR Technologies Market Breakdown by Offerings
        • 10.1.2.12.2.1 Rest of Asia Pacific PCR Technologies Market Breakdown by Instruments
        • 10.1.2.12.2.2 Rest of Asia Pacific PCR Technologies Market Breakdown by Reagents and Consumables
        • 10.1.2.12.2.2.1 Rest of Asia Pacific PCR Technologies Market Breakdown by Vial Size
        • 10.1.2.12.3 Rest of Asia Pacific PCR Technologies Market Breakdown by Application
        • 10.1.2.12.4 Rest of Asia Pacific PCR Technologies Market Breakdown by End User

11. PCR Technologies Market-Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in the PCR Technologies Market
  • 11.3 Inorganic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Organic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Thermo Fisher Scientific Inc
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Promega Corp
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 QIAGEN NV
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 bioMerieux SA
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Hoffmann-La Roche Ltd
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Bio-Rad Laboratories Inc
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Becton Dickinson and Co
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Takara Bio Inc
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Standard Biotools Inc
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 Agilent Technologies Inc
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments
  • 12.11 Ellume Ltd
    • 12.11.1 Key Facts
    • 12.11.2 Business Description
    • 12.11.3 Products and Services
    • 12.11.4 Financial Overview
    • 12.11.5 SWOT Analysis
    • 12.11.6 Key Developments

13. Appendix

  • 13.1 About the Insight Partners
  • 13.2 Glossary of Terms

List Of Tables

  • Table 1. PCR Technologies Market Segmentation
  • Table 2. PCR Technologies Market - Revenue and Forecast to 2030 (US$ Million) - By Technology
  • Table 3. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Offerings
  • Table 4. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Reagents and Consumables
  • Table 5. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Vial Size
  • Table 6. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Instruments
  • Table 7. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Application
  • Table 8. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By End User
  • Table 9. China PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Technology
  • Table 10. China PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Offerings
  • Table 11. China PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Instruments
  • Table 12. China PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Reagents and Consumables
  • Table 13. China PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Vial Size
  • Table 14. China PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Application
  • Table 15. China PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By End User
  • Table 16. Japan PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Technology
  • Table 17. Japan PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Offerings
  • Table 18. Japan PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Instruments
  • Table 19. Japan PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Reagents and Consumables
  • Table 20. Japan PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Vial Size
  • Table 21. Japan PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Application
  • Table 22. Japan PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By End User
  • Table 23. India PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Technology
  • Table 24. India PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Offerings
  • Table 25. India PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Instruments
  • Table 26. India PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Reagents and Consumables
  • Table 27. India PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Vial Size
  • Table 28. India PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Application
  • Table 29. India PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By End User
  • Table 30. Australia PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Technology
  • Table 31. Australia PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Offerings
  • Table 32. Australia PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Instruments
  • Table 33. Australia PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Reagents and Consumables
  • Table 34. Australia PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Vial Size
  • Table 35. Australia PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Application
  • Table 36. Australia PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By End User
  • Table 37. South Korea PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Technology
  • Table 38. South Korea PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Offerings
  • Table 39. South Korea PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Instruments
  • Table 40. South Korea PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Reagents and Consumables
  • Table 41. South Korea PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Vial Size
  • Table 42. South Korea PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Application
  • Table 43. South Korea PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By End User
  • Table 44. Rest of Asia Pacific PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Technology
  • Table 45. Rest of Asia Pacific PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Offerings
  • Table 46. Rest of Asia Pacific PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Instruments
  • Table 47. Rest of Asia Pacific PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Reagents and Consumables
  • Table 48. Rest of Asia Pacific PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Vial Size
  • Table 49. Rest of Asia Pacific PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Application
  • Table 50. Rest of Asia Pacific PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By End User
  • Table 51. Recent Inorganic Growth Strategies in the PCR Technologies Market
  • Table 52. Recent Organic Growth Strategies in the PCR Technologies Market
  • Table 53. Glossary of Terms, PCR Technologies Market

List Of Figures

  • Figure 1. PCR Technologies Market Segmentation, By Country
  • Figure 2. Impact Analysis of Drivers and Restraints
  • Figure 3. PCR Technologies Market Revenue (US$ Million), 2020 - 2030
  • Figure 4. PCR Technologies Market Share (%) - By Technology, 2022 and 2030
  • Figure 5. Real Time PCR Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 6. Conventional PCR Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 7. Reverse Transcription PCR Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 8. Digital PCR Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 9. Multiplex RT PCR Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 10. Hot Start PCR Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 11. Others Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 12. PCR Technologies Market Share (%) - By Offerings, 2022 and 2030
  • Figure 13. Reagents and Consumables Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 14. Instruments Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 15. Software and Services Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 16. PCR Technologies Market Share (%) - By Application, 2022 and 2030
  • Figure 17. Gene Expression Analysis Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 18. Genetic Sequencing Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 19. Genotyping Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 20. Nucleic Acid Synthesis Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 21. Standard Validation Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 22. Point of Care Diagnostics Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 23. Environmental Application Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 24. Others Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 25. PCR Technologies Market Share (%) - By End User, 2022 and 2030
  • Figure 26. Hospitals and Diagnostic Centers Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 27. Academia and Research Institutes Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 28. Pharmaceutical and Biotechnology Companies Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 29. Others Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 30. Asia Pacific: PCR Technologies Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 31. Asia Pacific PCR Technologies Market Breakdown by Key Countries, 2022 and 2030 (%)
  • Figure 32. China PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 33. Japan PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 34. India PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 35. Australia PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 36. South Korea PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 37. Rest of Asia Pacific PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 38. Growth Strategies in the PCR Technologies Market